The Cardiovascular Benefits Associated with the Use of Sodium-Glucose Cotransporter 2 Inhibitors – Real-World Data

Apr-18

Cardiovascular Pharmacoepidemiology

AUTHORS : Baptist Gallwitz, Department of Medicine IV, Eberhard Karls University of Tübingen, Tübingen, Germany – Email: baptist.gallwitz@med.uni-tuebingen.de

JOURNAL : European Endocrinology

REFERENCE: 14(1):17-23

DOI : 10.17925/EE.2018.14.1.17

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more